Evaluation of saliva levels and therapeutic effects of morinidazole, a new 5-nitroimidazole derivative, in patients with periodontal diseases
Yong-qing Wang*
Yong-qing Wang*
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.
Research Division of Clinical Pharmacology, the First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing, China, 210029, China.